These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of uterine leiomyomas by whole-genome sequencing. Mehine M; Kaasinen E; Mäkinen N; Katainen R; Kämpjärvi K; Pitkänen E; Heinonen HR; Bützow R; Kilpivaara O; Kuosmanen A; Ristolainen H; Gentile M; Sjöberg J; Vahteristo P; Aaltonen LA N Engl J Med; 2013 Jul; 369(1):43-53. PubMed ID: 23738515 [TBL] [Abstract][Full Text] [Related]
4. [Uterine leiomyoma and fumarate hydratase deficiency]. De Jesus J; Boudy AS; Varinot J; Just PA; Bendifallah S; Ilenko A; Daraï É Gynecol Obstet Fertil Senol; 2019 Mar; 47(3):324-326. PubMed ID: 30497940 [No Abstract] [Full Text] [Related]
5. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321 [TBL] [Abstract][Full Text] [Related]
6. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays. Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Je EM; Kim MR; Min KO; Yoo NJ; Lee SH Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225 [TBL] [Abstract][Full Text] [Related]
9. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628 [TBL] [Abstract][Full Text] [Related]
10. Genomics of uterine leiomyomas: insights from high-throughput sequencing. Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations. Xie J; Ubango J; Ban Y; Chakravarti D; Kim JJ; Wei JJ Genes Chromosomes Cancer; 2018 Oct; 57(10):485-494. PubMed ID: 29790226 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Commandeur AE; Styer AK; Teixeira JM Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720 [TBL] [Abstract][Full Text] [Related]
13. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity. de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas. Mäkinen N; Heinonen HR; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA Br J Cancer; 2014 Apr; 110(9):2246-9. PubMed ID: 24642626 [TBL] [Abstract][Full Text] [Related]
15. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas. Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526 [TBL] [Abstract][Full Text] [Related]
16. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients. Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726 [TBL] [Abstract][Full Text] [Related]
17. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer. Chan I; Wong T; Martinez-Mir A; Christiano AM; McGrath JA Clin Exp Dermatol; 2005 Jan; 30(1):75-8. PubMed ID: 15663510 [TBL] [Abstract][Full Text] [Related]
18. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives. Croce S; Chibon F Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152 [TBL] [Abstract][Full Text] [Related]
19. Global metabolomic profiling of uterine leiomyomas. Heinonen HR; Mehine M; Mäkinen N; Pasanen A; Pitkänen E; Karhu A; Sarvilinna NS; Sjöberg J; Heikinheimo O; Bützow R; Aaltonen LA; Kaasinen E Br J Cancer; 2017 Dec; 117(12):1855-1864. PubMed ID: 29073636 [TBL] [Abstract][Full Text] [Related]
20. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Di Tommaso S; Tinelli A; Malvasi A; Massari S Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]